title: [The compound "eric" in the treatment of bronchopulmonary diseases].
abstract: The drug erik was used in 32 patients with chronic bronchitis and acute bacterial pneumonia. Out of 132 strains assessed for sensitivity, 94 (68.6%) were sensitive to the above antibiotic, the rest demonstrated moderate sensitivity or drug resistance. The dose 0.5 g persisted in the blood for up to 12 hours allowing its use three times in 24 hours. The response was achieved in 32 patients (72.18%).
authors: V A
authors: VA
authors: Orlov
authors: V I
authors: VI
authors: Sokolova
authors: V A
authors: VA
authors: Shchenderovich
authors: S V
authors: SV
authors: Solomonova
authors: E A
authors: EA
authors: Ved'mina
mesh_terms: D000208:Acute Disease; D001991:Bronchitis / Q000188:drug therapy* / Q000382:microbiology; D002908:Chronic Disease; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D004917:Erythromycin
vernacular_title: Preparat "érik" v lechenii bronkholegochnykh zabolevaniĭ.